Malassezia pachydermatis fungaemia in a neonatal intensive care unit
- PMID: 11332175
Malassezia pachydermatis fungaemia in a neonatal intensive care unit
Abstract
Malassezia pachydermatis, a non-obligatory lipophilic yeast, has occasionally been implicated in nosocomial fungaemias. This study investigated a cluster of eight cases of M. pachydermatis infection and colonization in a neonatal intensive care unit over a 6 mo period. All patients were preterm with very low birthweight and suffered from various underlying diseases. Prolonged use of indwelling catheters and parenteral lipid formulations were important predisposing factors for their infection. All M. pachydermatis strains were susceptible to amphotericin B, fluconazole and itraconazole but resistant against flucytosine.
Conclusion: Molecular typing by random amplification of polymorphic DNA showed distinct banding profiles for each blood isolate. Since no epidemiological association among the strains could be shown, the reason for this cluster of nosocomial fungaemias remains unclear.
Similar articles
-
An epidemic of Malassezia pachydermatis in an intensive care nursery associated with colonization of health care workers' pet dogs.N Engl J Med. 1998 Mar 12;338(11):706-11. doi: 10.1056/NEJM199803123381102. N Engl J Med. 1998. PMID: 9494146
-
Nosocomial Malassezia pachydermatis bloodstream infections in a neonatal intensive care unit.Pediatr Infect Dis J. 1994 Feb;13(2):104-8. doi: 10.1097/00006454-199402000-00005. Pediatr Infect Dis J. 1994. PMID: 8190533
-
Etiology of fungaemia and catheter colonisation in Argentinean paediatric patients.Mycoses. 2006 Jan;49(1):49-54. doi: 10.1111/j.1439-0507.2005.01184.x. Mycoses. 2006. PMID: 16367819
-
Nosocomial transmission of Candida pelliculosa fungemia in a pediatric intensive care unit and review of the literature.Turk J Pediatr. 2010 Jan-Feb;52(1):42-9. Turk J Pediatr. 2010. PMID: 20402066 Review.
-
Invasive fungal infections caused by Candida and Malassezia species in the neonatal intensive care unit.Adv Neonatal Care. 2006 Apr;6(2):68-77; quiz 78-9. doi: 10.1016/j.adnc.2006.01.005. Adv Neonatal Care. 2006. PMID: 16618476 Review.
Cited by
-
Potential role of broad-spectrum azoles as therapy for Malasezzia bloodstream infection.Med Mycol Case Rep. 2023 May 12;41:1-3. doi: 10.1016/j.mmcr.2023.05.002. eCollection 2023 Sep. Med Mycol Case Rep. 2023. PMID: 37251705 Free PMC article.
-
Methodological Issues in Antifungal Susceptibility Testing of Malassezia pachydermatis.J Fungi (Basel). 2017 Jul 5;3(3):37. doi: 10.3390/jof3030037. J Fungi (Basel). 2017. PMID: 29371554 Free PMC article. Review.
-
Novel Antimicrobial Peptide from Temporin L in The Treatment of Staphylococcus pseudintermedius and Malassezia pachydermatis in Polymicrobial Inter-Kingdom Infection.Antibiotics (Basel). 2020 Aug 22;9(9):530. doi: 10.3390/antibiotics9090530. Antibiotics (Basel). 2020. PMID: 32842593 Free PMC article.
-
Comparison of Three Skin Sampling Methods and Two Media for Culturing Malassezia Yeast.J Fungi (Basel). 2020 Dec 9;6(4):350. doi: 10.3390/jof6040350. J Fungi (Basel). 2020. PMID: 33316902 Free PMC article.
-
Invasive Malassezia pachydermatis Infection in an 8-Year-Old Child on Lipid Parenteral Nutrition.Case Rep Infect Dis. 2022 Jan 20;2022:8636582. doi: 10.1155/2022/8636582. eCollection 2022. Case Rep Infect Dis. 2022. PMID: 35096432 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical